Connect with us
Information

Australia
North America
World

Investing News NetworkYour trusted source for investing success

North America
Australia
World
My INN

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides

Precious Metals
Battery Metals
Base Metals
Energy
Critical Metals

ritter pharmaceuticals

POPULAR ARTICLES

pharmaceutical investing

Ritter Pharmaceuticals Completes Dosing of Last Patient in Pivotal 557-Subject Phase 3 Clinical Trial

pharmaceutical investing

Ritter Pharmaceuticals Completes Enrollment in Pivotal Phase 3 Clinical Trial of RP-G28 in Patients with Lactose Intolerance

Ritter Pharmaceuticals Announces Agreement for $6.0 Million At-Market Private Placement

LATEST ARTICLES

pharmaceutical investing

Ritter Pharmaceuticals Announces Phase 3 Plans for RP-G28

pharmaceutical investing

Ritter Shares Additional Data from Phase 2b/3 Trial Results

pharmaceutical investing

Ritter Posts Financial Results for Q1 2017

pharmaceutical investing

Ritter Receives New Patents for Drug Development

Latest News

Harvest Gold Identifies 15 Primary And 10 Secondary Targets For Its Diamond Drill Program At Its Mosseau Project In Quebec

Juggernaut Files for Approval of Private Placement Financing

Empire Metals Limited Announces Warrant Exercise

HyProMag USA Receives "Make More in America" Domestic Finance Letter of Interest for up to US$92 Million From US EXIM Bank

Aston Bay and American West Metals Announce Drilling Preparations Underway at the Storm Project, Nunavut, Canada